← Back to headlines
Amgen and AstraZeneca Report Late-Stage Trial Success for Asthma Drug Tezspire
Pharmaceutical partners Amgen and AstraZeneca announced positive late-stage clinical trial results for Tezspire, demonstrating efficacy in treating a related swallowing disorder beyond its approved asthma indication.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
